Determination of the Degree of Esterification in Heparin Benzylates During Synthesis of Enoxaparin, a Domestic Analog of Low-Molecular-Mass Heparin
- Authors: Frumin L.E.1, Yur’eva K.P.1, Matveev A.V.1, Vorfolomeeva E.V.1,2, Vostrov I.A.2, Zatonskii G.V.3, Prokhorov D.I.1, Zhavoronok E.S.1,2, Panov A.V.1,2, Grebenkina L.E.1, Pyatigorskaya N.V.4, Brkich G.É.4, Kedik S.A.1,2
-
Affiliations:
- M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
- Institute of Pharmaceutical Technologies
- G. F. Gause Institute of New Antibiotics
- I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
- Issue: Vol 53, No 9 (2019)
- Pages: 852-857
- Section: Article
- URL: https://journals.rcsi.science/0091-150X/article/view/246033
- DOI: https://doi.org/10.1007/s11094-019-02089-7
- ID: 246033
Cite item
Abstract
The esterification stage of low-molecular-mass heparin (enoxaparin) production by hydrolytic depolymerization of unfractionated heparin was studied and consisted of treating previously synthesized benzethonium heparinate with benzyl chloride. The content of benzyl moieties in the synthesized heparin benzylates and their degree of benzylation were determined using HPLC, PMR, and 13C NMR methods. A carboxylic-acid content of 0.13 ± 0.01 mol/g in the starting heparin was calculated from these results. A new method for estimating the degree of heparin benzylation from PMR and HPLC data was proposed. The benzyl content in the heparin benzylates increased with increasing molar excess of benzyl chloride.
About the authors
L. E. Frumin
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
Email: kristina.yureva1994@mail.ru
Russian Federation, 78 Prosp. Vernadskogo, Moscow, 119454
K. P. Yur’eva
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
Author for correspondence.
Email: kristina.yureva1994@mail.ru
Russian Federation, 78 Prosp. Vernadskogo, Moscow, 119454
A. V. Matveev
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
Email: kristina.yureva1994@mail.ru
Russian Federation, 78 Prosp. Vernadskogo, Moscow, 119454
E. V. Vorfolomeeva
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies
Email: kristina.yureva1994@mail.ru
Russian Federation, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353
I. A. Vostrov
Institute of Pharmaceutical Technologies
Email: kristina.yureva1994@mail.ru
Russian Federation, Skolkovo, Moscow, 121353
G. V. Zatonskii
G. F. Gause Institute of New Antibiotics
Email: kristina.yureva1994@mail.ru
Russian Federation, 11 Bol’shaya Pirogovskaya St., Moscow, 119435
D. I. Prokhorov
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
Email: kristina.yureva1994@mail.ru
Russian Federation, 78 Prosp. Vernadskogo, Moscow, 119454
E. S. Zhavoronok
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies
Email: kristina.yureva1994@mail.ru
Russian Federation, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353
A. V. Panov
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies
Email: kristina.yureva1994@mail.ru
Russian Federation, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353
L. E. Grebenkina
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
Email: kristina.yureva1994@mail.ru
Russian Federation, 78 Prosp. Vernadskogo, Moscow, 119454
N. V. Pyatigorskaya
I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Email: kristina.yureva1994@mail.ru
Russian Federation, Moscow
G. É. Brkich
I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Email: kristina.yureva1994@mail.ru
Russian Federation, Moscow
S. A. Kedik
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies
Email: kristina.yureva1994@mail.ru
Russian Federation, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353